Urgent.News

What's breaking now, across thousands of outlets.

AI

Pharmacological and genetic access to astrocytic cholesterol programs in human neural cells

Astrocyte-neuron interactions coordinate cholesterol metabolism, cell adhesion, and synaptic gene expression1,2, and related gene expression programs decline together in schizophrenia3. Whether pharmacological or genetic perturbations can selectively engage components of this coordinated biology was unknown. Here we combine genetically diverse cultures of human stem-cell-derived neurons and…

Astrocyte-neuron interactions regulate cholesterol metabolism, cell adhesion, and synaptic gene expression. These interconnected programs exhibit declines in schizophrenia. The extent to which pharmacological or genetic interventions can selectively activate these interconnected processes had previously remained unclear.

Using stem-cell-derived cultures of human neurons and astrocytes, researchers applied a combination of genetic diversity, pharmacological profiling, genetic association mapping, and CRISPR interference to investigate these biological programs. In stem-cell-derived astrocyte cultures, the antipsychotic drug clozapine triggered a specific transcriptional response centered around cholesterol biosynthesis and export, leading to elevated levels of intracellular and secreted cholesterol.

This response mirrored the cholesterol-related component observed in astrocyte cultures co-cultured with neurons but did not extend to synaptic cell-adhesion genes.

When clozapine was introduced to neuron-astrocyte co-cultures, it further heightened neuronal firing activity. Across different cell donors, the induction of cholesterol-pathway genes by clozapine exhibited a broad range of responses, although there was a shared general trend. Gene-expression patterns in untreated donors demonstrated differential reactions to clozapine and the liver X receptor agonist GW3965.

Genetic variations common to the population influenced the expression of several cholesterol-related genes, with an association identified between HSD17B7 expression and nearby genetic variants. Notably, the repression of LDLR (low-density lipoprotein receptor) led to coordinated expression of cholesterol-biosynthesis genes in astrocytes, a response that aligned with clozapine's effects and neuronal contact signaling.

These findings reveal that pharmacological and genetic perturbations share common cholesterol-related transcriptional responses. Additionally, they establish a link between common genetic variation and distinct aspects of cholesterol-pathway reactions, providing new insights into astrocyte-neuron interactions and their roles in neurological disorders such as schizophrenia.

Written by urgent.news from bioRxiv's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at biorxiv.org →

More in AI

llm 0.37.3

Release: llm 0.37.3 A bug fix release for LLM , mainly to cover a problem with the most recent Homebrew package of the software.

More from Tuesday 17 November →